COMP <GO>
AGL vs MRK // EV/EBITDA & P/E VALUATION
agilon health inc. (NYSE) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: AGL 0
— MRK 10
■ METRIC PARITY
LAST: $85.94 (-5.56%) • MKT CAP: $1.44B
valuation
—
LAST: $146.33 (+3.83%) • MKT CAP: $361.02B
valuation
15.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AGL VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AGL | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 74.80% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 20.70% | -55.70 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -8.25% | 3.42% | -11.67 | MRK | /fcf-yield <GO> |
| Operating Margin | -7.80% | 34.30% | -42.10 | MRK | /operating-margins <GO> |
| Net Profit Margin | -6.60% | 28.10% | -34.70 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | -2.10% | 1.30% | -3.40 | MRK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.06 | 5.19 | -3.13 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 7/9 | -4.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.4 | 51.7 | -5.30 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.4x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.44B | $361.02B | -$359.58B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AGL REV | MRK REV | AGL GROSS % | MRK GROSS % | AGL FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.93B | $65.01B | — | 74.8% | -$119.0M | $12.36B |
| FY 2024 | $6.06B | $64.17B | — | 76.3% | -$71.0M | $18.10B |
| FY 2023 | $4.32B | $60.12B | — | — | -$156.2M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AGL // BETA —
MRK // BETA 0.92